In summary, increased expression of UBE2T in endometrial cancer tissues may suppress the anti-tumor immune response in UCEC patients, participating in various biological processes such as tumor initiation, metastasis, and invasion, and correlating with poorer survival rates. This evidence concerns the gene UBE2T and neoplasm.